Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

MDMA Therapy for PTSD Inches Closer to U.S. Approval

Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.

Rachel Nuwer
Author: Rachel Nuwer

Written by

Rachel Nuwer

in

Drug Enforcement Administration, Drugs (Pharmaceuticals), Ecstasy (Drug), Food and Drug Administration, MAPS Public Benefit Corporation, Post-Traumatic Stress Disorder, Psychiatry and Psychiatrists, Research, Therapy and Rehabilitation
←Spain’s Female Soccer Players Call Off Wage Dispute Strike
How Tim Flannery, the Giants Coach, Got Back to Writing Songs→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube